Metagenomi Inc. Dives into IPO Wave, Aims for $100M Raise
Emeryville-based biotech firm, Metagenomi Inc., makes headlines as it dives into the IPO market, eyeing a substantial $100 million raise to fuel its groundbreaking...
Merck Animal Health’s $1.3B Buy Of Fish Biz
In a strategic move set to make waves in the pharmaceutical arena, Merck Animal Health announced on Monday its plans to acquire Elanco Animal...
Companies To Pay $7.5M To End ERISA Class Action
A significant resolution has emerged in a legal battle as a security services firm and its 401(k) manager agreed to pay a total of...
NC $13.5M settlement with First National Bank
The U.S. Department of Justice and North Carolina's attorney general have announced a groundbreaking $13.5 million settlement with First National Bank (FNB), a regional...
Acerinox to Acquire Haynes International: A Billion-Dollar Steel Symphony
In a groundbreaking move set to redefine the landscape of high-performance alloy manufacturing, Acerinox, the stainless steel giant, has orchestrated a stunning acquisition, positioning...
Thoma Bravo Aquires Everbridge for $1.5 billion
In a seismic move reverberating across financial markets, Thoma Bravo, guided by Kirkland & Ellis LLP, has sealed a deal to acquire Everbridge, represented...
NanoString Files for Bankruptcy Amid Patent Infringement Battle
Seattle-based NanoString Technologies Inc. and its affiliates have taken a drastic step by filing for Chapter 11 protection in Delaware bankruptcy court, swallowed by...
Yandex To Sell Russian Businesses For $5.2B
In a seismic move, Yandex, the internet titan, announced Monday a jaw-dropping decision to offload its Russian business to a consortium for a staggering...
Cano Health Files For Bankruptcy : Financial Predicament Unveiled
In a startling revelation, Cano Health Inc., a prominent primary care group, has initiated Chapter 11 protection proceedings in Delaware bankruptcy court, unveiling plans...
Novo Holdings Buying Catalent In $16.5B Deal
In a seismic move within the pharmaceutical industry, Novo Holdings, the controlling shareholder in Novo Nordisk Foundation, has unveiled plans to acquire Catalent in...